Comparing the outcome between multicentric and multifocal breast cancer: What is the impact on survival, and is there a role for guideline-adherent adjuvant therapy? A retrospective multicenter cohort study of 8,935 patients

Breast Cancer Research and Treatment

Volumn 142, Issue 3, 2013, Pages 579-590

  Wolters, R ^b   Wockel A ^a   Janni, W ^a   Novopashenny, I ^b   Ebner, F ^a   Kreienberg, R ^a   Wischnewsky, M ^b   Schwentner, L ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b UNIVERSITY OF BREMEN   (Germany)

Author keywords

Breast cancer; Cohort study; Guideline adherence; Multicentric; Multifocal; Survival

Indexed keywords

AROMATASE INHIBITOR; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; GONADORELIN AGONIST; METHOTREXATE; TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER MORTALITY; CANCER SIZE; CANCER SURVIVAL; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GERMANY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; MULTICENTER STUDY; MULTIPLE CANCER; OUTCOME ASSESSMENT; PARTIAL MASTECTOMY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTOCOL COMPLIANCE; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; GUIDELINE ADHERENCE; HUMANS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84890312205     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-013-2772-y     Document Type: Article

References (35)

1. Rakha EA, Ellis IO (2009) Triple-negative/basal-like breast cancer: review. Pathology 41(1):40-47
2. Ihemelandu CU, Lefall LD Jr, Dewitty RL, Naab TJ, Mezghebe HM, Makambi KH, Adams-Campbell L, Frederick WA (2007) Molecular breast cancer subtypes in premenopausal and postmenopausal African-American women: age-specific prevalence and survival. J Surg Res 143(1):109-118
3. Wiechmann L, Sampson M, Stempel M, Jacks LM, Patil SM, King T, Morrow M (2009) Presenting features of breast cancer differ by molecular subtype. Ann Surg Oncol 16(10):2705-2710
4. Ibrahim E, Al-Gahmi AM, Zeenelin AA, Zekri JM, Elkhodary TR, Gaballa HE, Fawzy EE, El Sayed ME, Alzahrani MS (2009) Basal vs. luminal A breast cancer subtypes: a matched case-control study using estrogen receptor, progesterone receptor, and Her-2 as surrogate markers. Med Oncol 26(3):372-378
5. Lynch SP, Lei X, Chavez-MacGregor M, Hsu L, Meric-Bernstam F, Buchholz TA, Zhang A, Hortobagyi GN, Valero V, Gonzalez-Angulo AM (2012) Multifocality and multicentricity in breast cancer and survival outcomes. Ann Oncol 23(12):3063-3069
6. Yerushalmi R, Kennecke H, Woods R, Olivotto IA, Speers C, Gelmon KA (2009) Does multicentric/multifocal breast cancer differ from unifocal breast cancer? An analysis of survival and contralateral breast cancer incidence. Breast Cancer Res Treat 117(2):365-370
7. Egan RL (1982) Multicentric breast carcinomas: clinical-radiographic- pathologic whole organ studies and 10-year survival. Cancer 49:1123-1130
8. Wilkinson LS, Given-Wilson R, Hall T, Potts H, Sharma AK, Smith E (2005) Increasing the diagnosis of multifocal primary breast cancer by the use of bilateral whole-breast ultrasound. Clin Radiol 60(5):573-578
9. Sardanelli F, Giuseppetti GM, Panizza P, Bazzocchi M, Fausto A, Simonetti G, Lattanzio V, Del Maschio A (2004) Sensitivity of MRI versus mammography for detecting foci of multifocal, multicentric breast cancer in fatty and dense breasts using the whole-breast pathologic examination as a gold standard. AJR Am J Roentgenol 183:1149-1157
10. Houssami N, Ciatto S, Macaskill P, Lord SJ, Warren RM, Dixon JM, Irwig L (2008) Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. J Clin Oncol 26(19):3248-3258
11. Cabioglu N, Ozmen V, Kaya H, Tuzlali S, Igci A, Muslumanoglu M, Kecer M, Dagoglu T (2009) Increased lymph node positivity in multifocal and multicentric breast cancer. J Am Coll Surg 208(1):67-74
12. Andea AA, Wallis T, Newman LA, Bouwman D, Dey J, Visscher DW (2002) Pathologic analysis o tumor size and lymph node status in multifocal/ multicentric breast carcinoma. Cancer 94(5):1383-1390
13. Pedersen L, Gunnarsdottir KA, Rasmussen BB, Moeller S, Lanng C (2004) The prognostic influence of multifocality in breast cancer patients. Breast 13(3):188-193
14. Weissenbacher TM, Zschage M, Janni W, Jeschke U, Dimpfl T, Mayr D, Rack B, Schindlbeck C, Friese K, Dian D (2010) Multicentric and multifocal versus unifocal breast cancer: is the tumor-node-metastasis classification justified? Breast Cancer Res Treat 122(1):27-34
15. Rezo A, Dahlstrom J, Shadbolt B, Rodins K, Zhang Y, Davis AJ (2011) Tumor size and survival in multicentric and multifocal breast cancer. Breast 20(3):259-263
16. Tot T, Gere M, Pekar G, Tarjan M, Hofmeyer S, Hellberg D, Lindquist D, Chen TH, Yen AM, Chiu SY, Tabar L (2011) Breast cancer multifocality, disease extent, and survival. Human Pathol 42:1761-1769
17. Litton JK, Eralp Y, Gonzalez-Angulo AM, Broglio K, Uyei A, Hortobagyi GN, Arun B (2007) Multifocal breast cancer in women < or =35 years old. Cancer 110(7):1445-1450
18. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (2010) AJCC Cancer staging manual. Springer, New York
19. Lester SC, Bose S, Chen YY, Connolly JL, de Baca ME, Fitzgibbons PL, Hayes DF, Kleer C, O'Malley FP, Page DL, Smith BL, Tan LK, Weaver DL, Winer E (2009) Protocol for the examination of specimens from patients with invasive carcinoma of the breast. Arch Pathol Lab Med 133:1515-1538
20. Schouten LJ, Jager JJ, van den Brandt PA (1993) Quality of cancer registry data: a comparison of data provided by clinicians with those of registrations personnel. Br J Cancer 68(5):974-977
21. Wolters R, Regierer AC, Schwentner L, Geyer V, Possinger K, Kreienberg R, Wischnewsky MB, Wöckel A (2012) A comparision of international breast cancer guidelines-Do the national guidelines differ in treatment recommendations? Eur J Cancer 48(1):1-11
22. Kreienberg R, Kopp I, Albert U, et al. (2008) Interdisciplinary S3 guideline for diagnosis and therapy of breast cancer in women. German Cancer Society, Berlin
23. Boyages J, Jayasinghe UW, Coombs N (2010) Multifocal breast cancer and survival: each focus does matter particularly for larger tumors. Eur J Cancer 46:1990-1996
24. Hamaker ME, Schreurs WH, Uppelschoten JM, Smorenburg CH (2009) Breast cancer in the elderly: retrospective study on diagnosis and treatment according to national guidelines. Breast J 15:26-33
25. Schwentner L, Wolters R, Wischnewsky MB, Kreienberg R, Wöckel A (2012) Survival of patients with bilateral versus unilateral breast cancer and impact of guideline adherent adjuvant treatment: a multi-centre cohort study of 5,292 patients. Breast 21(2):171-177
26. Schwentner L, Wolters R, Koretz K, Wischnewsky MB, Kreienberg R, Rottscholl R, Wöckel A (2012) Triple-negative breast cancer: the impact of guideline-adherent adjuvant treatment on survival-a retrospective multi-centre cohort study. Breast Cancer Res Treat 132(3):1073-1080
27. Hancke K, Denkinger MD, König J, Kurzeder C, Wöckel A, Herr D, Blettner M, Kreienberg R (2010) Standard treatment of female patients with breast cancer decreases substantially for women aged 70 years and older: a German Clinical Cohort Study. Ann Oncol 21(4):748-753
28. Janssen-Heijnen ML, Maas HA, Lemmens VE, Houterman S, Louwman WJ, Verheij CD, Coebergh JW (2005) The correlation of age and comorbidity with therapy and survival in cancer patients in North-Brabant and North-Limburg, 1995-2001. Ned Tijdschr Geneeskd 149(30):1686-1690
29. DeMichele A, Putt M, Zhang Y, Glick JH, Norman S (2003) Older age predicts a decline in adjuvant chemotherapy recommendations for patients with breast carcinoma: evidence from a tertiary care cohort of chemotherapy-eligible patients. Cancer 97(9):2150-2159
30. Craft PS, Buckingham JM, Dahlstrom JE, Beckmann KR, Zhang Y, Stuart-Harris R, Jacob G, Roder D, Tait N (2010) Variation in the management of early breast cancer in rural and metropolitan centres: implications fort he organisation of rural cancer services. Breast 19(5):396-401
31. Hebert-Croteau N, Brisson J, Latreille J, Rivard M, Abdelaziz N, Martin G (2004) Compliance with consensus recommendations for systemic therapy is associated with improved survival of women with nodal negative breast cancer. J Clinical Oncol 22:3685-3693
32. Gentilini O, Botteri E, Rotmensz N, Da Lima L, Caliskan M, Garcia-Etienne CA, Sosnovskikh I, Intra M, Mazzarol G, Musmeci S, Veronesi P, Galimberti V, Luini A, Viale g, Goldhirsch A, Veronesi U (2009) Conservative surgery in patients with multifocal/multicentric breast cancer. Breast Cancer Res Treat 113(3):577-583
33. Yerushalmi R, Tyldesley S, Woods R, Kennecke HF, Speers C, Gelmon KA (2012) Is breast-conserving therapy a safe option for patients with tumor multicentricity and multifocality? Ann Oncol 23(4):876-881
34. Bauman L, Barth RJ, Rosenkranz KM (2010) Breast conservation in women with multifocal-multicentric breast cancer: is it feasible? Ann Surg Oncol 17(3):325-329
35. Chung AP, Huynh K, Kidner T, Mirzadehgan P, Sim MS, Giuliano AE (2012) Comparision of outcomes of breast conserving therapy in multifocal and unifocal invasive breast cancer. J Am Coll Surg 215(1):137-146